Mylan (MYL) Stock: Headed Up On FDA Approval
Mylan NV (NASDAQ: MYL) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that the United States Food and Drug Administration has approved one of its treatments. Of course, the news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk … Read more